Comments on India’s draft biotech patent guidelines posted

Peter Leung, Hong Kong


The India Patent Office has released public feedback to its draft guidelines for the examination of biotechnology patents

The guidelines were released on December 11 2013 with a public comment period until January 11. The Patent Office received comments from Indian biotechnology firms, patent law firms, and groups such as the Organisation of Pharmaceuticals Producers of India (OPPO), the Biotechnology Industry Organization (BIO) and even the Japan Intellectual Property...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

China: Excessive pricing and standard-essential patents (sponsored) http://t.co/3exBD9aY8l

Jul 29 2014 02:15 ·  reply ·  retweet ·  favourite
ManagingIP profile

Australia: Injunction granted to block second medical use (sponsored) http://t.co/CaAKbDjEnZ #patent

Jul 28 2014 10:15 ·  reply ·  retweet ·  favourite
ManagingIP profile

United States: Test for indefiniteness remains indefinite after Nautilus v Biosig #patent (sponsored) http://t.co/yAlfkxY4RJ

Jul 28 2014 04:01 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in Hong Kong



July/August 2014

IP’s most influential people 2014

The 50 people in social media, advocacy and debate influencing IP policy



Most read articles

Supplements